Your session is about to expire
← Back to Search
PET Imaging for Depression
Study Summary
This trial is designed to study whether COX-1 and COX-2 are detectable in the brains of individuals with MDD experiencing a major depressive episode (MDE).
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Media Library
- I am between 18 and 70 years old.You have been diagnosed with major depression by a mental health professional using the DSM-5 criteria and a structured interview.I have been feeling depressed for at least four weeks.I am in good health overall, as confirmed by my doctor.You are in good health according to your doctor's evaluation.You must have completed a mental and emotional health screening test called "The Evaluation of Patients with Mood and Anxiety Disorders and Healthy Participants" as part of the study eligibility process.You must understand the tests and procedures involved in the study and be willing to sign a document stating you agree to participate.You must have symptoms of depression with a score of 18 or higher on MADRS or a score of 15 or higher on HAM-D within one week of starting the study.I haven't taken any medications for at least two weeks, or five weeks for specific drugs, before my first screening.If you are a woman who could become pregnant, you need to be using a reliable form of birth control.
- Group 1: One Arm
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Who meets the criteria to take part in this investigation?
"This medical trial is sourcing 64 individuals between 18 to 70 years old who are suffering from depression. Furthermore, they must adhere to the following conditions: male or female gender identity; comprehension of all clinical tests and examinations; females with childbearing potential need contraception; general healthiness as indicated by their history and physical exam; passed screening assessment under 01-M-0254 protocol ; minimum 4 weeks duration for MDE symptoms; medication-free status (5 weeks in case of aripiprazole, brexpiprazole, fluoxetine); primary care provider/inhouse clinician approved stable medical condition(s); DSM 5"
What risks might be associated with this particular treatment?
"Following a review of the clinical data, our team at Power assigned this treatment a score of 1. This is because it is currently in Phase 1 trials with limited evidence supporting its safety and effectiveness."
Is this study open to those under eighty-five years of age?
"This research project has set the minimum age for participants at 18 years old and capped off enrolment by those 70 or older."
What is the aggregate amount of participants in this clinical experiment?
"Yes, this trial is actively enrolling patients. Per the information housed on clinicaltrials.gov, it was first posted on July 20th 2021 and last updated on September 22nd 2022; 64 individuals are sought after to join the single study site."
Are there any vacancies remaining in this experiment for participants?
"The clinical trial is actively searching for participants, as evidenced by the information hosted on clinicialtrials.gov. The investigation was first posted in July 2021 and subsequently updated in September 2022."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
How responsive is this trial?
Typically responds via
Most responsive sites:
- National Institutes of Health Clinical Center: < 24 hours
Average response time
- < 1 Day
Share this study with friends
Copy Link
Messenger